Epidolex is the first cannabis and cannabidiol (CBD)-based drug approved by the FDA and specifically treats Lennox-Gastaut syndrome and Dravet syndrome.
CBD Administered During Peri-Adolescence Prevents Behavioral Abnormalities in Rats with an Animal Model of Schizophrenia
This study aimed to help prevent the emergence of schizophrenia in peri-adolescence by administering CBD to rats with an animal model of schizophrenia.
The study evaluated the effects of varying doses of CBD and a placebo in 57 healthy adult male volunteers who performed a simulated public speaking test.
Hemp is a super material: it's soft, naturally bacteria resistant, UV resistant, long lasting and gets softer with use.
Researchers test CBD's ability to restore functional autophagy, reduce inflammation and positively enhance muscle function.
Both children and adults that received CBD, in conjunction with their traditional anti-epileptic medications, experienced a significant decrease in drop seizures during the trial with minimal adverse effects.
Cannabis has shown to have anti-inflammatory and anti-hyperalgesia (lowering of pain response) properties, but the exact plant components causing these effects were the target of this study.